MA26447A1 - Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant - Google Patents

Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant

Info

Publication number
MA26447A1
MA26447A1 MA24865A MA24865A MA26447A1 MA 26447 A1 MA26447 A1 MA 26447A1 MA 24865 A MA24865 A MA 24865A MA 24865 A MA24865 A MA 24865A MA 26447 A1 MA26447 A1 MA 26447A1
Authority
MA
Morocco
Prior art keywords
same
pharmaceutical compositions
compositions containing
peptide analogs
analogs
Prior art date
Application number
MA24865A
Other languages
English (en)
Inventor
Delansorne Remi
Paris Jacques
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of MA26447A1 publication Critical patent/MA26447A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/23Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/13Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
MA24865A 1996-11-14 1997-11-12 Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant MA26447A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96402441A EP0842946A1 (fr) 1996-11-14 1996-11-14 Analogues de LHRH à conformation forcée, leur utilisation et composés pharmaceutiques

Publications (1)

Publication Number Publication Date
MA26447A1 true MA26447A1 (fr) 2004-12-20

Family

ID=8225315

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24865A MA26447A1 (fr) 1996-11-14 1997-11-12 Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant

Country Status (28)

Country Link
US (1) US6153587A (fr)
EP (2) EP0842946A1 (fr)
JP (1) JP2001503444A (fr)
KR (1) KR20000068975A (fr)
CN (1) CN1237979A (fr)
AP (1) AP9901529A0 (fr)
AT (1) ATE196914T1 (fr)
AU (1) AU5481798A (fr)
BR (1) BR9713060A (fr)
CA (1) CA2270158A1 (fr)
CO (1) CO4930283A1 (fr)
CZ (1) CZ172899A3 (fr)
DE (1) DE69703308D1 (fr)
EE (1) EE9900174A (fr)
HU (1) HUP0000249A3 (fr)
ID (1) ID21990A (fr)
IL (1) IL129821A0 (fr)
JO (1) JO1999B1 (fr)
MA (1) MA26447A1 (fr)
NO (1) NO992298L (fr)
NZ (1) NZ335454A (fr)
OA (1) OA11045A (fr)
PE (1) PE16899A1 (fr)
PL (1) PL333358A1 (fr)
TN (1) TNSN97173A1 (fr)
TR (1) TR199901054T2 (fr)
WO (1) WO1998021229A1 (fr)
ZA (1) ZA9710254B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
EP0842946A1 (fr) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Analogues de LHRH à conformation forcée, leur utilisation et composés pharmaceutiques
EP0882736A1 (fr) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant
EP0998940A1 (fr) * 1998-09-30 2000-05-10 Laboratoire Theramex Compositions pharmaceutiques à base de alpha-cyclodextrine pour administration orale d'analogues de LH-RH
WO2000064926A1 (fr) * 1999-04-26 2000-11-02 Ajinomoto Co., Inc. Inhibiteur hormonal stimulant les melanocytes
US8821943B2 (en) * 2006-09-12 2014-09-02 Board Of Regents Of The University Of Nebraska Methods and compositions for targeted delivery of therapeutic agents
JP2023546032A (ja) * 2020-10-08 2023-11-01 ディグニファイ セラピューティクス エルエルシー 排尿および排便を誘発するための組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377515A (en) * 1979-10-01 1983-03-22 Merck & Co., Inc. Long lasting agonists and antagonists of LH-RH
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
EP0842946A1 (fr) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Analogues de LHRH à conformation forcée, leur utilisation et composés pharmaceutiques

Also Published As

Publication number Publication date
CA2270158A1 (fr) 1998-05-22
US6153587A (en) 2000-11-28
EP0937101B1 (fr) 2000-10-11
PE16899A1 (es) 1999-02-19
EP0842946A1 (fr) 1998-05-20
CO4930283A1 (es) 2000-06-27
CZ172899A3 (cs) 1999-08-11
ID21990A (id) 1999-08-19
JP2001503444A (ja) 2001-03-13
WO1998021229A1 (fr) 1998-05-22
AP9901529A0 (en) 1999-06-30
ZA9710254B (en) 1998-05-28
TR199901054T2 (xx) 1999-07-21
CN1237979A (zh) 1999-12-08
IL129821A0 (en) 2000-02-29
DE69703308D1 (de) 2000-11-16
TNSN97173A1 (fr) 2005-03-15
EP0937101A1 (fr) 1999-08-25
ATE196914T1 (de) 2000-10-15
NO992298L (no) 1999-07-08
KR20000068975A (ko) 2000-11-25
NO992298D0 (no) 1999-05-12
AU5481798A (en) 1998-06-03
BR9713060A (pt) 2000-04-11
EE9900174A (et) 1999-12-15
HUP0000249A3 (en) 2000-11-28
NZ335454A (en) 2000-10-27
OA11045A (en) 2003-03-07
PL333358A1 (en) 1999-12-06
HUP0000249A2 (en) 2000-07-28
JO1999B1 (en) 1999-05-15

Similar Documents

Publication Publication Date Title
MA26502A1 (fr) Analogues peptidiques de la lh-rh, leur utilisation et les compositions pharmaceutiques les contenant.
DZ2086A1 (fr) Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
BR9611367A (pt) Formulação farmacêutic liofilizada estável
FR2696094B1 (fr) Nouvelles compositions pharmaceutiques contenant des cyclosporines.
CY2005007I1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
IS4706A (is) Lyfjasamsetningar
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
DE69614407D1 (de) Pharmazeutische zusammensetzungen
MA26447A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant
BR9605046B1 (pt) compostos n-(pirimidinl)-benzenossulfonamida e preparação farmacêutica contendo as mesmas.
PL334125A1 (en) Novel analogues of camphotecin, their application as drugs and pharmaceutic agents containing them
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
FR2753707B1 (fr) Complexes nucleopeptidiques, compositions cosmetologiques et pharmaceutiques les contenant et utilisations
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
DE69521315D1 (de) Hirudin enthaltende pharmazeutische zusammensetzungen
BR9611619B1 (pt) ciclopeptolìdeos e composição farmacêutica que os contêm.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
IT8521622A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo acetil -10triacetossi-1,8,9 antracene.
MX9203261A (es) Nuevas 12-amino-piridazino [4',5':3,4] pirrolo[2,1-a]-isoquinolinas y composiciones farmaceuticas que las contienen.
FI972988A (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
BR1100782A (pt) Fenilimidazolidinas substituìdas, sua aplicação como medicamentos e as composições farmacêuticas que as contêm